This case study is an anonymised composite based on publicly reported commercial insurance claim patterns. It is not actual Apex client data and does not constitute legal or insurance advice. Names, locations and identifying details have been changed. Apex Insurance Brokers Limited is authorised and regulated by the Financial Conduct Authority, FRN 724952.
A specialist temperature-controlled logistics operator based in the Midlands, around 35 articulated tractor and refrigerated trailer units, turnover £11m. The firm operates trunk routes between distribution centres and customer sites for food and pharmaceutical clients, with a mix of own-fleet and subcontracted capacity. The firm operates under standard Road Haulage Association (RHA) Conditions of Carriage for most customers and under bespoke pharmaceutical-customer contracts for a small number of higher-value contracts. Insurance includes a combined haulier policy with goods-in-transit cover at £500,000 per vehicle, motor fleet cover, employers’ liability and combined liability.
A trailer load of high-value pharmaceutical products being transported from a Midlands distribution centre to a customer’s regional hub in the South of England was lost in transit. The shipment comprised twenty-four pallets of a cold-chain biologic product with a manufacturer-stated value of approximately £1.8m for the consignment. The trailer was lost when the driver, deviating from the planned route to attend an unscheduled stop near his home address (approximately twenty miles off the planned route) and leaving the vehicle unattended in a layby for approximately ninety minutes during a break period, returned to find the trailer missing. The tractor unit, separately locked at the front of the layby, remained in place.
The Driver and Vehicle Standards Agency was notified, the police were called, and a regional and national alert was issued. The trailer was located approximately seven hours later at an abandoned industrial site approximately forty miles away, with the load substantially intact. However, the temperature monitoring system on the trailer showed that the refrigeration unit had been switched off during the period of theft, and the cold-chain integrity of the pharmaceutical load had been compromised. The manufacturer’s quality assurance team assessed the load and determined that the entire shipment had to be destroyed as it could not be guaranteed to meet the temperature-controlled chain of custody required for pharmaceutical product release.
The customer immediately notified the firm of the loss and intimated a claim for the full consignment value plus consequential losses.
The customer’s pleaded loss was approximately £2.1m: full consignment value at £1.8m on the basis of pharmaceutical wholesale acquisition cost, replacement consignment additional cost (the product had a long manufacturing lead time and the replacement was charged at premium pricing) of approximately £180,000, customer’s onward distribution adjustments and customer compensation £80,000, and the customer’s internal investigation and supply chain management costs of approximately £40,000.
The contractual framework was central. The shipment had been contracted under a bespoke pharmaceutical-customer agreement that included a comprehensive cold-chain integrity clause, an unlimited value declaration that displaced the standard RHA Conditions of Carriage limitation per consignment, and an indemnity from the firm to the customer in respect of all losses arising from breach of the cold-chain requirements.
The firm’s goods-in-transit cover was at £500,000 per vehicle, materially below the consignment value. The firm had been aware of the cover gap and had been in discussions with the broker about raising the limit on pharmaceutical contracts, but the renewal of the increased cover had not yet been effected at the date of the loss.
The goods-in-transit (GIT) cover responded up to its £500,000 per-vehicle limit, less the £2,500 each-and-every-loss excess. However, two coverage points were raised by the insurer.
First, the deviation point. The GIT policy contained a standard condition that cover applied to “goods carried in the ordinary course of the insured’s business” and that “the vehicle and load shall be at all times accompanied by the driver or driver’s mate except during such absences as may be reasonably necessary for taking refreshment or rest in accordance with the driver’s hours regulations”. The driver’s deviation from the planned route to attend an unscheduled stop near his home address, and the absence from the vehicle for approximately ninety minutes in an unattended layby, prima facie engaged the conditions on cover. The insurer’s coverage position was that the deviation defeated indemnity.
The firm’s argument, advanced through specialist marine and transit cover counsel, was that the deviation was a personal matter by the driver rather than a deviation by the firm, that the firm had no knowledge of or authority for the deviation, and that the condition should be construed narrowly to avoid penalising the firm for the driver’s unauthorised personal conduct. The argument relied on the general principle that policy conditions should be applied proportionately under the Insurance Act 2015.
Second, the unattended-vehicle point. The condition required reasonable absence during refreshment or rest in accordance with driver’s hours regulations. The ninety-minute absence in a non-secure layby for personal reasons did not meet either condition. The insurer’s position was firm on this point.
After approximately eighteen months of correspondence and a coverage mediation, the parties reached a commercial settlement at approximately £320,000 (representing approximately 64% of the per-vehicle limit), without either party conceding the underlying coverage position.
The combined liability policy was put on notice in respect of the customer’s contractual indemnity claim. The contractual liability extension responded subject to a £100,000 sub-limit. The remaining customer claim was the subject of extended commercial negotiation, with the firm contesting parts of the claim on quantum grounds and the customer contesting parts of the firm’s commercial proposal. The matter eventually settled at approximately £1.2m total, of which the firm’s insurance contribution was approximately £420,000 across the GIT and combined liability covers, and the firm’s uninsured exposure was approximately £780,000.
The firm’s uninsured exposure of £780,000 was met through a combination of cash reserves and a working capital facility. The firm’s relationship with the pharmaceutical customer was severely damaged and the customer terminated the supply arrangement at the next contractual review point. The loss of this customer represented approximately £1.4m of annual revenue.
The driver was the subject of internal disciplinary proceedings and his employment was terminated. The DVSA’s regulatory engagement closed with no further action beyond a documented record. The combined haulier policy renewed with a 110% premium increase and the GIT cover was rewritten with a £2m per-vehicle limit for pharmaceutical and other high-value cargo, a £25,000 each-and-every-loss excess, and a comprehensive set of conditions on driver behaviour, vehicle parking and unattended-vehicle restrictions.
The firm implemented a tracker-and-immobiliser upgrade across the trailer fleet, instituted a route-management protocol with real-time deviation alerts to the operations centre, and introduced a “no unauthorised stops” disciplinary policy. The combined liability contractual liability extension was reviewed and the sub-limit was increased to £500,000.
Goods-in-transit cover is one of the most condition-laden areas of commercial insurance and one where the gap between the headline limit and the realistic claim exposure can be substantial. First, the GIT per-vehicle limit must reflect the realistic consignment value, particularly for pharmaceutical, electronics and other high-value cargo categories; standard limits of £25,000 or £100,000 are inadequate for any high-value cargo customer. Second, the contractual framework with high-value cargo customers typically includes value declarations and indemnity clauses that displace the standard RHA Conditions of Carriage limitation; the GIT cover must be benchmarked against the contract terms, not the standard conditions. Third, deviation and unattended-vehicle conditions are increasingly enforced rigorously and the driver behaviour requirements should be embedded in driver training, route planning and disciplinary procedures. Fourth, the combined liability contractual liability extension is the second layer of cover for contract indemnity claims and the sub-limit should reflect the realistic indemnity exposure under the firm’s contract portfolio. Fifth, real-time tracking and route-management technology is no longer optional in the high-value cargo sector; the cost is trivial against the cost of a contested deviation claim.
We would have benchmarked the GIT per-vehicle limit against the realistic consignment value on the pharmaceutical customer’s contract at the previous renewal, and would have effected the limit increase at renewal rather than allowing it to be deferred mid-term. The driver behaviour conditions on the GIT policy would have been reviewed against the firm’s operational practice with documented compliance protocols. At notification, we would have managed the insurer engagement on the deviation argument from day one, and would have coordinated the customer engagement on the contractual indemnity claim alongside the GIT and combined liability claims. The Insurance Act 2015 proportionate remedy argument is one that has to be deployed crisply and early; left until the insurer has formed a settled view, it becomes an uphill push.
For the underlying cover, see our Transport & logistics insurance hub.
Apex Insurance Brokers serves UK professional services firms and commercial businesses. Call 0117 325 0027, email hello@apexinsurancebrokers.co.uk, or request a quotation.
Get a quote